Pneumococcal vaccine GSK2189242A

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, Streptococcal

Phase 1

Evaluation of Pneumococcal Vaccine Formulations in Young Adults

CompletedNCT00707798

GlaxoSmithKlineInfections, Streptococcal

Start: 2008-06-30End: 2009-01-15Updated: 2017-05-10

Phase 2

Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children

CompletedNCT01545375

GlaxoSmithKlineInfections, Streptococcal

Start: 2012-05-21End: 2016-07-26Updated: 2019-12-27

Related Papers

Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study

Vaccine2019-10-1640 citations

Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study.

2014-03-0652 citations